Edouard Leroy
Co-Founder & Chief Executive Officer Antelope Therapeutics
Edouard Leroy, Co-Founder and CEO of Antelope Therapeutics, is a biologist by training. He spent his career in the life sciences industry, most recently he served as the Chief Business Officer of Mablink Bioscience, a French ADC startup acquired by Eli Lilly in 2023.
Seminars
Thursday 10th September 2026
Finding a Gap: Achieving Good Response Rates in Difficult Tumor Types
3:00 pm
- How do established payloads compare in their ability to drive meaningful clinical responses?
- Have historically pursued targets lacked sufficient expression or accessibility to enable effective tumor penetration?
- What role can mechanisms play in increasing efficacy?
